Regorafenib in Relapsed Glioblastoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study aims to evaluate the role of Regorafenib in prolonging the overall survival of glioblastoma multiforme patients who progressed after surgery and Stupp regimen with or without bevacizumab.
Epistemonikos ID: d14a8b95cfd3c6161c67922d79a1c0b63624ac9c
First added on: May 17, 2024